Cargando…
Identification of TIM3 2′-fluoro oligonucleotide aptamer by HT-SELEX for cancer immunotherapy
TIM3 belongs to a family of receptors that are involved in T-cell exhaustion and Treg functions. The development of new therapeutic agents to block this type of receptors is opening a new avenue in cancer immunotherapy. There are currently several clinical trials ongoing to combine different immune-...
Autores principales: | Hervas-Stubbs, Sandra, Soldevilla, Mario M., Villanueva, Helena, Mancheño, Uxua, Bendandi, Maurizio, Pastor, Fernando |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826223/ https://www.ncbi.nlm.nih.gov/pubmed/26683225 http://dx.doi.org/10.18632/oncotarget.6608 |
Ejemplares similares
-
Identification of LAG3 high affinity aptamers by HT-SELEX and Conserved Motif Accumulation (CMA)
por: Soldevilla, Mario Martínez, et al.
Publicado: (2017) -
MRP1-CD28 bi-specific oligonucleotide aptamers: target costimulation to drug-resistant melanoma cancer stem cells
por: Soldevilla, Mario Martínez, et al.
Publicado: (2016) -
Aptamers Against Live Targets: Is In Vivo SELEX Finally Coming to the Edge?
por: Sola, Mayte, et al.
Publicado: (2020) -
Aptamers: A Feasible Technology in Cancer Immunotherapy
por: Soldevilla, M. M., et al.
Publicado: (2016) -
CD28 Aptamers as Powerful Immune Response Modulators
por: Pastor, Fernando, et al.
Publicado: (2013)